3378 — Hanx Biopharmaceuticals (Wuhan) Share News
0.000.00%
- HK$3.59bn
- HK$3.10bn
Brief: Hanx Biopharmaceuticals (Wuhan)Enters Agreement To Establish Joint Ai-Driven Drug Discovery Lab
Brief: Hanx Biopharmaceuticals (Wuhan) And Twinedge Bioscience Initiates Research Collaboration
Farmers in biggest cocoa producer are very short of fertilizer, survey says
Brief: Hanx Biopharmaceuticals (Wuhan) Says Xiao Jieyu Re-Designated As Executive Director
Brief: Hanx Biopharmaceuticals (Wuhan) Says HX111 Received Approval For Clinical Trials In China
Brief: Hanx Biopharmaceuticals (Wuhan) Sets Final Offer Price HK$32.00 Per H Share